Plain-English translation of NCT06382051 on ClinicalTrials.gov ↗ · Source last updated · Translation generated · How we translate trials
This study doesn't follow the usual testing phases — it may be an observational study or a different type of research.
This trial is testing whether an updated version of a screening questionnaire — called PEST+pictures+2 — can better identify psoriatic arthritis (a type of joint disease that can develop in people with psoriasis) in patients with moderate-to-severe skin psoriasis. The study asks patients to answer screening questions at their dermatologist visit, and those who screen positive will see a rheumatologist for a full evaluation. The goal is to catch joint disease earlier so patients can get treated sooner.
Many people with psoriasis develop joint problems without realizing it, and delays in diagnosis can lead to lasting joint damage. This trial aims to improve the screening tool so that healthcare providers can identify these joint problems faster and more accurately in patients who are already being treated for their skin condition.
You likely qualify if…
You likely don't qualify if…
You will visit your dermatologist for an initial appointment where you'll complete a screening questionnaire with pictures to help identify signs of joint disease — this takes about an hour. If your screening results suggest you may have joint problems, you'll have a second visit with a rheumatologist who will do a thorough evaluation. About 4 months after your first visit, your dermatologist will contact you remotely to ask about any biologic treatment you may have started. The entire study lasts up to 120 days.
AI-generated summary from trial data · Jul 18, 2026 · Not medical advice
Canada